NDC 53157-455

Leukotrap - CP2D

Anticoagulant Citrate Phosphate Double Dextrose

Leukotrap - CP2D is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Haemonetics Corporation. The primary component is Dextrose, Unspecified Form.

Product ID53157-455_e154f8b7-89a1-dfbb-e053-2995a90a300a
NDC53157-455
Product TypeHuman Prescription Drug
Proprietary NameLeukotrap - CP2D
Generic NameAnticoagulant Citrate Phosphate Double Dextrose
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-10-09
Marketing CategoryNDA /
Application NumberBN820915
Labeler NameHaemonetics Corporation
Substance NameDEXTROSE, UNSPECIFIED FORM
Active Ingredient Strength5 g/100mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 53157-455-02

250 mL in 1 BAG (53157-455-02)
Marketing Start Date2019-10-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Leukotrap - CP2D" or generic name "Anticoagulant Citrate Phosphate Double Dextrose"

NDCBrand NameGeneric Name
53157-455Leukotrap - CP2DANTICOAGULANT CITRATE PHOSPHATE DOUBLE DEXTROSE
53157-123Leukotrap - CP2D SolutionAnticoagulant Citrate Phosphate Double Dextrose

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.